Basis of Presentation and Summary of Significant Accounting Policies - Summary of condensed consolidated statement of operations and comprehensive loss reflecting the adoption of ASC 842 (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Costs and operating expenses:
Research and development	$ 144,282	$ 290,059	$ 306,921	$ 613,635	[1]
General and administrative	102,341	438,427	213,774	873,195	[1]
Total operating expenses	264,719	792,397	561,166	1,636,173	[1]
Loss from operations	(184,151)	(647,779)	(399,896)	(1,323,150)	[1]
Other income (expense):
Interest Income (Expense), Net	14,349	2,264	28,894	2,441	[1]
Other income (expense), net:	(3,224)	(230)	(6,152)	(2,149)	[1]
Total other income (expense), net	10,903	(22,836)	21,761	59,758	[1]
Loss before income taxes	(173,248)	(670,615)	(378,135)	(1,263,392)	[1]
Net Loss	(173,315)	(670,570)	(378,284)	(1,263,163)	[1]
Net loss attributable to Ginkgo Bioworks Holdings, Inc. stockholders	$ (173,315)	(668,825)	$ (378,284)	(1,259,330)	[1]
Adjustments [Member]
Costs and operating expenses:
Research and development		871		1,727
Total operating expenses		871		1,727
Loss from operations		(871)		(1,727)
Other income (expense):
Interest Income (Expense), Net		590		1,164
Other income (expense), net:		281		563
Total other income (expense), net		871		1,727
As Adjusted [Member]
Costs and operating expenses:
Research and development		290,059		613,635
Total operating expenses		792,397		1,636,173
Loss from operations		(647,779)		(1,323,150)
Other income (expense):
Interest Income (Expense), Net		2,264		2,441
Other income (expense), net:		230		2,149
Total other income (expense), net		(22,836)		59,758
As Previously Reported [Member]
Costs and operating expenses:
Research and development		289,188		611,908
Total operating expenses		791,526		1,634,446
Loss from operations		(646,908)		(1,321,423)
Other income (expense):
Interest Income (Expense), Net		1,674		1,277
Other income (expense), net:		(51)		1,586
Total other income (expense), net		$ (23,707)		$ 58,031

[1] As adjusted to reflect the impact of the adoption of Accounting Standards Codification Topic 842, Leases (“ASC 842”) as of January 1, 2022. See Note 1 for a summary of the adjustments.